The N-glycosyltransferase STT3 promotes PD-L1 N-glycosylation, which is essential for PD-L1 upregulation during epithelial-mesenchymal transition (EMT), contributing to cancer cell immune evasion in preclinical models [128]. This evidence concerns the gene CD274 and cancer.